Compare DOMH & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOMH | STSS |
|---|---|---|
| Founded | 1967 | 2017 |
| Country | United States | United States |
| Employees | N/A | 55 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 43.8M |
| IPO Year | 2010 | N/A |
| Metric | DOMH | STSS |
|---|---|---|
| Price | $3.64 | $2.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 85.7K | ★ 306.8K |
| Earning Date | 05-12-2026 | 04-06-2026 |
| Dividend Yield | ★ 23.45% | N/A |
| EPS Growth | ★ 34.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $123,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 578.41 | N/A |
| 52 Week Low | $2.69 | $1.42 |
| 52 Week High | $8.40 | $18.23 |
| Indicator | DOMH | STSS |
|---|---|---|
| Relative Strength Index (RSI) | 68.30 | 62.51 |
| Support Level | $2.75 | $1.97 |
| Resistance Level | $5.09 | $2.00 |
| Average True Range (ATR) | 0.19 | 0.09 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 95.79 | 98.15 |
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.